These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32635785)

  • 1. Synthesis and structure-activity relationships of novel 5-(hydroxamic acid)methyl oxazolidinone derivatives as 5-lipoxygenase inhibitors.
    Phillips OA; Bosso MA; Ezeamuzie CI
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1471-1482. PubMed ID: 32635785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-allergic, anti-asthmatic and anti-inflammatory effects of an oxazolidinone hydroxamic acid derivative (PH-251) - A novel dual inhibitor of 5-lipoxygenase and mast cell degranulation.
    Ezeamuzie CI; Rao MS; El-Hashim AZ; Philip E; Phillips OA
    Int Immunopharmacol; 2022 Apr; 105():108558. PubMed ID: 35091338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dibenzoxepinone hydroxylamines and hydroxamic acids: dual inhibitors of cyclooxygenase and 5-lipoxygenase with potent topical antiinflammatory activity.
    Hamer RR; Tegeler JJ; Kurtz ES; Allen RC; Bailey SC; Elliott ME; Hellyer L; Helsley GC; Przekop P; Freed BS; White J; Martin LL
    J Med Chem; 1996 Jan; 39(1):246-52. PubMed ID: 8568814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of novel 5-(hydroxamic acid)methyl oxazolidinone derivatives.
    Phillips OA; D'Silva R; Bahta TO; Sharaf LH; Udo EE; Benov L; Eric Walters D
    Eur J Med Chem; 2015 Dec; 106():120-31. PubMed ID: 26536532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzothiazole hydroxy ureas as inhibitors of 5-lipoxygenase: use of the hydroxyurea moiety as a replacement for hydroxamic acid.
    Greco MN; Hageman WE; Powell ET; Tighe JJ; Persico FJ
    J Med Chem; 1992 Aug; 35(17):3180-3. PubMed ID: 1324317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on 5-lipoxygenase inhibitors. I. Synthesis and 5-lipoxygenase-inhibitory activity of novel hydroxamic acid derivatives.
    Yatabe T; Kawai Y; Oku T; Tanaka H
    Chem Pharm Bull (Tokyo); 1998 Jun; 46(6):966-72. PubMed ID: 9658575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based design, semi-synthesis and anti-inflammatory activity of tocotrienolic amides as 5-lipoxygenase inhibitors.
    Dinh CP; Ville A; Neukirch K; Viault G; Temml V; Koeberle A; Werz O; Schuster D; Stuppner H; Richomme P; Helesbeux JJ; Séraphin D
    Eur J Med Chem; 2020 Sep; 202():112518. PubMed ID: 32668380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-clinical pharmacology of ICI D2138, a potent orally-active non-redox inhibitor of 5-lipoxygenase.
    McMillan RM; Spruce KE; Crawley GC; Walker ER; Foster SJ
    Br J Pharmacol; 1992 Dec; 107(4):1042-7. PubMed ID: 1334748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural insight into the optimization of ethyl 5-hydroxybenzo[g]indol-3-carboxylates and their bioisosteric analogues as 5-LO/m-PGES-1 dual inhibitors able to suppress inflammation.
    Bruno F; Errico S; Pace S; Nawrozkij MB; Mkrtchyan AS; Guida F; Maisto R; Olgaç A; D'Amico M; Maione S; De Rosa M; Banoglu E; Werz O; Fiorentino A; Filosa R
    Eur J Med Chem; 2018 Jul; 155():946-960. PubMed ID: 30015253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azole phenoxy hydroxyureas as selective and orally active inhibitors of 5-lipoxygenase.
    Malamas MS; Carlson RP; Grimes D; Howell R; Glaser K; Gunawan I; Nelson JA; Kanzelberger M; Shah U; Hartman DA
    J Med Chem; 1996 Jan; 39(1):237-45. PubMed ID: 8568813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-Mediated Intracellular Donation of Nitric Oxide Potently Inhibits 5-Lipoxygenase: A Possible Key to Future Antileukotriene Therapy.
    Roos J; Peters M; Maucher IV; Kühn B; Fettel J; Hellmuth N; Brat C; Sommer B; Urbschat A; Piesche M; Vogel A; Proschak E; Blöcher R; Buscató E; Häfner AK; Matrone C; Werz O; Heidler J; Wittig I; Angioni C; Geisslinger G; Parnham MJ; Zacharowski K; Steinhilber D; Maier TJ
    Antioxid Redox Signal; 2018 May; 28(14):1265-1285. PubMed ID: 28699354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and biological evaluation of novel 1,2-diaryl-4-substituted-benzylidene-5(4H)-imidazolone derivatives as cytotoxic agents and COX-2/LOX inhibitors.
    Lamie PF; Philoppes JN; Rárová L
    Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700311. PubMed ID: 29400411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further studies on ethyl 5-hydroxy-indole-3-carboxylate scaffold: design, synthesis and evaluation of 2-phenylthiomethyl-indole derivatives as efficient inhibitors of human 5-lipoxygenase.
    Peduto A; Bruno F; Dehm F; Krauth V; de Caprariis P; Weinigel C; Barz D; Massa A; De Rosa M; Werz O; Filosa R
    Eur J Med Chem; 2014 Jun; 81():492-8. PubMed ID: 24871899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and biological evaluation of some novel indolizine derivatives as dual cyclooxygenase and lipoxygenase inhibitor for anti-inflammatory activity.
    Shrivastava SK; Srivastava P; Bandresh R; Tripathi PN; Tripathi A
    Bioorg Med Chem; 2017 Aug; 25(16):4424-4432. PubMed ID: 28669741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of NSAIDs as lipoxygenase inhibitors through highly sensitive chemiluminescence method, expression analysis in mononuclear cells and computational studies.
    Shahid W; Ejaz SA; Al-Rashida M; Saleem M; Ahmed M; Rahman J; Riaz N; Ashraf M
    Bioorg Chem; 2021 May; 110():104818. PubMed ID: 33784531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships of (E)-3-(1,4-benzoquinonyl)-2-[(3-pyridyl)-alkyl]-2-propenoic acid derivatives that inhibit both 5-lipoxygenase and thromboxane A2 synthetase.
    Hibi S; Okamoto Y; Tagami K; Numata H; Kobayashi N; Shinoda M; Kawahara T; Harada K; Miyamoto K; Yamatsu I
    J Med Chem; 1996 Aug; 39(16):3148-57. PubMed ID: 8759636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of a series of hydroxamic acid derivatives on 5-lipoxygenase and cyclooxygenase from neutrophils and 12-lipoxygenase from platelets and their in vivo effects on inflammation and anaphylaxis.
    Huang FC; Shoupe TS; Lin CJ; Lee TD; Chan WK; Tan J; Schnapper M; Suh JT; Gordon RJ; Sonnino PA
    J Med Chem; 1989 Aug; 32(8):1836-42. PubMed ID: 2502629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity analysis of a class of orally active hydroxamic acid inhibitors of leukotriene biosynthesis.
    Summers JB; Gunn BP; Martin JG; Martin MB; Mazdiyasni H; Stewart AO; Young PR; Bouska JB; Goetze AM; Dyer RD
    J Med Chem; 1988 Oct; 31(10):1960-4. PubMed ID: 3172130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and biological evaluation of novel 1,4-benzoquinone and related resorcinol derivatives that inhibit 5-lipoxygenase.
    Filosa R; Peduto A; Aparoy P; Schaible AM; Luderer S; Krauth V; Petronzi C; Massa A; de Rosa M; Reddanna P; Werz O
    Eur J Med Chem; 2013 Sep; 67():269-79. PubMed ID: 23871907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phorbol ester-induced dermal inflammation in mice: evaluation of inhibitors of 5-lipoxygenase and antagonists of leukotriene B4 receptor.
    Rao TS; Yu SS; Djuric SW; Isakson PC
    J Lipid Mediat Cell Signal; 1994 Sep; 10(3):213-28. PubMed ID: 7812673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.